levodopa has been researched along with 4-butyrolactone in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (46.15) | 18.7374 |
1990's | 5 (38.46) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (7.69) | 24.3611 |
2020's | 1 (7.69) | 2.80 |
Authors | Studies |
---|---|
Ekman, A; Eriksson, E | 1 |
Bohmaker, K; Friedhoff, AJ; Goldstein, M; Meller, E; Namba, Y | 1 |
Adler, CH; Bohmaker, K; Friedhoff, AJ; Goldstein, M; Helmer-Matyjek, E; Meller, E | 1 |
Haubrich, DR; Pflueger, AB | 1 |
Kikuchi, T; Watanabe, H; Watanabe, K | 1 |
Jin, GZ; Li, JH; Wang, XL; Yu, LP | 1 |
Hefti, F; Melamed, E | 1 |
Basham, DA; Bohmaker, K; Goldstein, M; Meller, E | 1 |
Carruba, MO; da Prada, M; Imhof, R; Nisoli, E; Scherschlicht, R; Tonello, C | 1 |
Bonnet, JJ; Costentin, J; Thibaut, F; Vaugeois, JM | 2 |
Han, Y; Lau, AS; Qi, H; Rong, J; Zhao, J | 1 |
Bentley, WE; Hörnström, D; Järbur, I; Payne, GF; Pitzer, J; Sjöberg, G; van Maris, AJA; VanArsdale, E | 1 |
13 other study(ies) available for levodopa and 4-butyrolactone
Article | Year |
---|---|
Effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on the prolactin suppression induced by a series of full and partial dopamine D2 receptor agonists in male rats.
Topics: 4-Butyrolactone; Adrenergic alpha-Antagonists; Animals; Apomorphine; Dopamine Agents; Ergolines; Levodopa; Male; Piperidines; Prolactin; Quinolines; Rats; Rats, Sprague-Dawley | 1992 |
Relationship between receptor occupancy and response at striatal dopamine autoreceptors.
Topics: 4-Butyrolactone; Adrenergic alpha-Antagonists; Animals; Apomorphine; Corpus Striatum; Dihydroxyphenylalanine; Homeostasis; Hydrazines; Levodopa; Male; Piperidines; Quinolines; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1987 |
Receptor reserve at striatal dopamine autoreceptors: implications for selectivity of dopamine agonists.
Topics: 4-Butyrolactone; Animals; Apomorphine; Corpus Striatum; Indoles; Levodopa; Male; Quinolines; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1986 |
The autoreceptor control of dopamine synthesis. An in vitro and in vivo comparison of dopamine agonists.
Topics: 4-Butyrolactone; Animals; Corpus Striatum; Dopamine; Haloperidol; In Vitro Techniques; Levodopa; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Synaptosomes; Tyrosine; Tyrosine 3-Monooxygenase | 1982 |
Effects of d-coclaurine and d-reticuline, benzyltetrahydroisoquinoline alkaloids, on levels of 3,4-dihydroxyphenylacetic acid and homovanillic acid in the mouse striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; 4-Butyrolactone; Alkaloids; Animals; Antipsychotic Agents; Benzylisoquinolines; Corpus Striatum; Homovanillic Acid; Injections, Intraventricular; Isoquinolines; Levodopa; Male; Mice; Phenylacetates | 1983 |
[Effect of tetrahydroberberine on blockade of pre- and postsynaptic dopamine receptors (author's transl)].
Topics: 4-Butyrolactone; Animals; Apomorphine; Berberine; Berberine Alkaloids; Corpus Striatum; Hypnotics and Sedatives; Levodopa; Rats; Receptors, Dopamine | 1982 |
Dopamine release in rat striatum after administration of L-dope as studied with in vivo electrochemistry.
Topics: 4-Butyrolactone; Amphetamine; Animals; Carbidopa; Corpus Striatum; Dopamine; Electrochemistry; Haloperidol; Levodopa; Male; Pargyline; Rats; Rats, Inbred Strains | 1981 |
Evidence that striatal synthesis-inhibiting autoreceptors are dopamine D3 receptors.
Topics: 4-Butyrolactone; Animals; Apomorphine; Corpus Striatum; Dopamine Agents; Dose-Response Relationship, Drug; Levodopa; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Stereoisomerism | 1993 |
Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
Topics: 4-Butyrolactone; Adenylyl Cyclases; Amphetamine; Animals; Apomorphine; Biogenic Monoamines; Brain; Catalepsy; Corpus Striatum; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Levodopa; Locomotion; Male; Motor Activity; Perfusion; Potassium; Quinolines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Receptors, Serotonin; Stereotyped Behavior; Synapses; Tetrahydronaphthalenes; Time Factors; Tritium | 1993 |
In vivo striatal binding of the D1 antagonist SCH 23390 is not modified by changes in dopaminergic transmission.
Topics: 4-Butyrolactone; Animals; Benzazepines; Cerebellum; Corpus Striatum; Dextroamphetamine; Dopamine; Dopamine Agents; Levodopa; Male; Mice; Receptors, Dopamine D1 | 1996 |
Pharmacological modifications of dopamine transmission do not influence the striatal in vivo binding of [3H]mazindol or [3H]cocaine in mice.
Topics: 4-Butyrolactone; Analysis of Variance; Animals; Cerebellum; Cocaine; Dextroamphetamine; Dopamine; Dopamine Agents; Dopamine Uptake Inhibitors; GABA Modulators; Injections, Intravenous; Levodopa; Mazindol; Mice; Neostriatum; Protein Binding; Tritium | 1996 |
Z-ligustilide potentiates the cytotoxicity of dopamine in rat dopaminergic PC12 cells.
Topics: 4-Butyrolactone; Acetylcysteine; Animals; Apoptosis; Bisbenzimidazole; Cell Count; DNA Fragmentation; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Flow Cytometry; Glutathione; Levodopa; Neuroprotective Agents; PC12 Cells; Rats; Reactive Oxygen Species; Time Factors | 2012 |
A Coculture Based Tyrosine-Tyrosinase Electrochemical Gene Circuit for Connecting Cellular Communication with Electronic Networks.
Topics: 4-Butyrolactone; Culture Media; Electrochemical Techniques; Electrodes; Gold; Levodopa; Monophenol Monooxygenase; Oxidation-Reduction; Plasmids; Pseudomonas aeruginosa; Pyocyanine; Quorum Sensing; Synthetic Biology; Tyrosine | 2020 |